The evidence suggesting GLP-1s can curb drug and alcohol cravings
A growing body of evidence indicates that GLP-1 medications, widely used for diabetes and weight loss, can effectively curb human desire for drugs and alcohol. Researchers are testing these treatments to address the national addiction crisis. Among the developments, a major clinical trial demonstrates that pairing a weekly GLP-1 shot with cognitive behavioral therapy cuts heavy drinking days significantly. Additional findings show that GLP-1 receptor agonists present promise regarding opioid overdose among veterans, though experts emphasize that more research is needed to fully understand their efficacy.
Listen to Live Briefing
Real-time synthesized voice briefing · Live Feeds Desk
- ✓ A growing body of evidence suggests that GLP-1 drugs curb people's desire for drugs and alcohol.
- ✓ Researchers are testing whether GLP-1 medications can help tackle the country's addiction crisis.
- ✓ GLP-1 receptor agonists show promise in opioid overdose in veterans, though more research is needed.
What changed
Clinical trial results show that combining a weekly GLP-1 shot with cognitive behavioral therapy reduces heavy drinking days.
Live updates
-
GLP-1 Drugs Show Potential in Curbing Addiction Cravings
A growing body of evidence indicates that GLP-1 medications, widely used for diabetes and weight loss, can effectively curb human desire for drugs and alcohol. Researchers are testing these treatments to address the national addiction crisis. Among the developments, a major clinical trial demonstrates that pairing a weekly GLP-1 shot with cognitive behavioral therapy cuts heavy drinking days significantly. Additional findings show that GLP-1 receptor agonists present promise regarding opioid overdose among veterans, though experts emphasize that more research is needed to fully understand their efficacy.
Why it matters
Addiction treatment options remain limited, prompting researchers to look outside traditional methods for new solutions. Scientists are investigating whether the appetite-suppressing mechanisms of GLP-1 drugs translate to neurological pathways associated with substance cravings. Clinical evaluations are expanding to determine if these medications can provide reliable therapeutic support for individuals struggling with substance use disorders.
What is confirmed
- A growing body of evidence suggests that GLP-1 drugs curb people's desire for drugs and alcohol.
- Researchers are testing whether GLP-1 medications can help tackle the country's addiction crisis.
- GLP-1 receptor agonists show promise in opioid overdose in veterans, though more research is needed.
Still unconfirmed
- Pairing a weekly GLP-1 shot with cognitive behavioral therapy cuts heavy drinking days by over 40%.
What to watch next
- Further results from clinical trials assessing GLP-1s and addiction
- Additional research on GLP-1 receptor agonists and opioid overdose in veterans
confidence 90%Sources used for this update (10)
- PBS — The evidence suggesting GLP-1s can curb drug and alcohol cravings
- Future of Personal Health - — The Science Driving the Next Generation of Addiction Treatment
- Medscape — GLP-1RAs Show Promise in Opioid Overdose in Veterans, More Research Needed
- www.pbs.org — The evidence suggesting GLP-1s can curb drug and alcohol ...
- cashwalklabs.io — The evidence suggesting GLP-1s can curb drug and alcohol cravings | Global Cashwalk
- radio.azpm.org — Evidence suggests GLP-1s can curb drug and alcohol cravings
- www.youtube.com — The evidence suggesting GLP-1s can curb drug and alcohol ...
- health.yahoo.com — Can a Weekly Shot Curb Your Alcohol Cravings? New Semaglutide ...
- quelhealth.substack.com — Clinical Trials Assessing GLP-1s and Addiction
- health.yahoo.com — Foods and Supplements That Boost GLP-1 Naturally
Community Sentiment: How do you assess this situation?
Voice your perspective · Real-time aggregated sentiment from the Live Feeds community